These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 25725035)
1. Increased Platelet to Lymphocyte Ratio is Related to Slow Coronary Flow. Akboga MK; Canpolat U; Balci KG; Akyel A; Sen F; Yayla C; Cay S; Aras D; Aydogdu S Angiology; 2016 Jan; 67(1):21-6. PubMed ID: 25725035 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493 [TBL] [Abstract][Full Text] [Related]
3. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation. Canpolat U; Çetin EH; Cetin S; Aydin S; Akboga MK; Yayla C; Turak O; Aras D; Aydogdu S Clin Appl Thromb Hemost; 2016 Jul; 22(5):476-82. PubMed ID: 26139836 [TBL] [Abstract][Full Text] [Related]
4. Serum YKL-40 is increased in patients with slow coronary flow. Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow. Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833 [TBL] [Abstract][Full Text] [Related]
6. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow. Barutcu I; Sezgin AT; Sezgin N; Gullu H; Esen AM; Topal E; Ozdemir R; Kosar F; Cehreli S Angiology; 2007; 58(4):401-7. PubMed ID: 17652225 [TBL] [Abstract][Full Text] [Related]
7. The relationship between neutrophil gelatinase-associated lipocalin levels and the slow coronary flow phenomenon. Aksan G; Soylu K; Aksoy O; Özdemir M; Yanik A; Yuksel S; Gedikli Ö; Gulel O; Sahin M Coron Artery Dis; 2014 Sep; 25(6):505-9. PubMed ID: 24801557 [TBL] [Abstract][Full Text] [Related]
8. Plateletcrit and red cell distribution width are independent predictors of the slow coronary flow phenomenon. Akpinar I; Sayin MR; Gursoy YC; Aktop Z; Karabag T; Kucuk E; Sen N; Aydin M; Kiran S; Buyukuysal MC; Haznedaroglu IC J Cardiol; 2014 Feb; 63(2):112-8. PubMed ID: 24012331 [TBL] [Abstract][Full Text] [Related]
9. Relationship between neutrophil to lymphocyte ratio and slow coronary flow. Doğan M; Akyel A; Çimen T; Bilgin M; Sunman H; Kasapkara HA; Arslantaş U; Yayla KG; Açıkel S; Yeter E Clin Appl Thromb Hemost; 2015 Apr; 21(3):251-4. PubMed ID: 23892686 [TBL] [Abstract][Full Text] [Related]
10. Increased mean platelet volume in patients with slow coronary flow. Sen N; Basar N; Maden O; Ozcan F; Ozlu MF; Gungor O; Cagli K; Erbay AR; Balbay Y Platelets; 2009 Feb; 20(1):23-8. PubMed ID: 19172518 [TBL] [Abstract][Full Text] [Related]
11. Serum Salusin-β Levels Are Correlated with Slow Coronary Flow. Wang T; Dong AH; Cao HY Genet Test Mol Biomarkers; 2016 Jul; 20(7):393-7. PubMed ID: 27227272 [TBL] [Abstract][Full Text] [Related]
12. Association of Platelet to Lymphocyte Ratio With Inflammation and Severity of Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease. Akboga MK; Canpolat U; Yayla C; Ozcan F; Ozeke O; Topaloglu S; Aras D Angiology; 2016 Jan; 67(1):89-95. PubMed ID: 25922197 [TBL] [Abstract][Full Text] [Related]
13. Clinical analysis of the risk factors of slow coronary flow. Xia S; Deng SB; Wang Y; Xiao J; Du JL; Zhang Y; Wang XC; Li YQ; Zhao R; He L; Xiang YL; She Q Heart Vessels; 2011 Sep; 26(5):480-6. PubMed ID: 21207039 [TBL] [Abstract][Full Text] [Related]
14. Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study. Durakoğlugil ME; Kocaman SA; Çetin M; Kirbaş A; Canga A; Erdoğan T; Çiçek Y Anadolu Kardiyol Derg; 2013 Feb; 13(1):39-44. PubMed ID: 23070634 [TBL] [Abstract][Full Text] [Related]
15. Relationship between platelet-to-lymphocyte ratio and coronary slow flow. Oylumlu M; Doğan A; Oylumlu M; Yıldız A; Yüksel M; Kayan F; Kilit C; Amasyalı B Anatol J Cardiol; 2015 May; 15(5):391-5. PubMed ID: 25430406 [TBL] [Abstract][Full Text] [Related]
16. The effects of endothelial dysfunction and inflammation on slow coronary flow. Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102 [TBL] [Abstract][Full Text] [Related]
17. Could Pan-Immune-Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon? Kaplangoray M; Toprak K; Deveci E; Caglayan C; Şahin E Cardiovasc Toxicol; 2024 May; 24(5):519-526. PubMed ID: 38622332 [TBL] [Abstract][Full Text] [Related]
18. Acute phase reactants in patients with coronary slow flow phenomenon. Madak N; Nazlı Y; Mergen H; Aysel S; Kandaz M; Yanık E; Cekdemir D; Tavlı T Anadolu Kardiyol Derg; 2010 Oct; 10(5):416-20. PubMed ID: 20929698 [TBL] [Abstract][Full Text] [Related]
19. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360 [TBL] [Abstract][Full Text] [Related]
20. Increased serum resistin levels in patients with coronary slow-flow phenomenon. Canga A; Cetin M; Kocaman SA; Durakoğlugil ME; Kırbaş A; Erdoğan T; Temiz A; Yılmaz A; Ciçek Y Herz; 2013 Nov; 38(7):773-8. PubMed ID: 23400345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]